Global Non-opioid Pain Patch Market to Reach $5.1 Billion by 2030
The global market for Non-opioid Pain Patch estimated at US$4.3 Billion in the year 2022, is projected to reach a revised size of US$5.1 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2022-2030. Lidocaine Patches, one of the segments analyzed in the report, is projected to record 2.5% CAGR and reach US$1.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Diclofenac Patches segment is readjusted to a revised 2% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 3.9% CAGR
The Non-opioid Pain Patch market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.5% and 1.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 0.9% CAGR.Select Competitors (Total 42 Featured) -
- Acorda Therapeutics, Inc.
- Allergan PLC
- Endo Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Hisamitsu Pharmaceutical Co., Inc.
- IBSA Institut Biochimique SA
- Mylan NV
- Pfizer, Inc.
- TEH SENG Pharmaceutical Mfg. Co., Ltd.
- Teikoku Seiyaku Co. Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acorda Therapeutics, Inc.
- Allergan PLC
- Endo Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Hisamitsu Pharmaceutical Co., Inc.
- IBSA Institut Biochimique SA
- Mylan NV
- Pfizer, Inc.
- TEH SENG Pharmaceutical Mfg. Co., Ltd.
- Teikoku Seiyaku Co. Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.3 Billion |
Forecasted Market Value ( USD | $ 5.1 Billion |
Compound Annual Growth Rate | 2.2% |
Regions Covered | Global |